Related Experiment Video

Updated: Oct 2, 2026

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on: July 28, 2010

Prevalence of somatic alterations in the colorectal cancer cell genome

Tian-Li Wang1, Carlo Rago, Natalie Silliman

  • 1Howard Hughes Medical Institute and The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medical Institutions, Baltimore, MD 21231, USA.

Proceedings of the National Academy of Sciences of the United States of America
|February 28, 2002
PubMed

Insights

Most sporadic colorectal cancers do not show a mutator phenotype at the nucleotide level. This study found few somatic mutations in tumor DNA, suggesting normal mutation rates in most colorectal tumors.

Area of Science:

  • Genetics
  • Oncology
  • Molecular Biology

Background:

  • A small fraction of human cancers exhibit increased somatic mutation rates due to DNA repair deficiencies.
  • The prevalence of somatic alterations in the majority of human cancers remains largely unknown.
  • Understanding somatic mutation patterns is crucial for cancer research and treatment.

Purpose of the Study:

  • To systematically assess nonsynonymous somatic alterations in colorectal neoplasia.
  • To determine the mutation rate in tumor cells compared to normal cells.
  • To investigate the implications for identifying tumor-suppressor genes.

Main Methods:

  • DNA sequencing of approximately 3.2 Mb of coding tumor DNA.
  • Analysis of 1,811 exons from 470 genes in colorectal tumor samples.
  • Identification and characterization of nonsynonymous somatic mutations.

Main Results:

  • Only three distinct somatic mutations were identified across all samples analyzed.
  • The identified mutations included two missense changes and one 14-bp deletion.
  • The rate of somatic alteration was approximately one per Mb of tumor DNA, similar to normal cells.

Conclusions:

  • Most sporadic colorectal cancers do not display a mutator phenotype at the nucleotide level.
  • The observed mutation rate suggests that DNA repair mechanisms are largely functional in these tumors.
  • These findings have significant implications for the interpretation of somatic mutations in candidate tumor-suppressor genes.

More Related Videos

Quantification of Colonic Stem Cell Mutations07:53

Quantification of Colonic Stem Cell Mutations

Published on: September 25, 2015

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mutations02:27

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously during DNA replication or be induced by environmental factors. Mutations can be characterized in several ways: by whether and how they alter the amino acid sequence of the protein, by the scale of the DNA affected, and by whether they affect somatic or germline cells.Consequences of Point Mutations at the Molecular LevelMutations that affect a single nucleotide are called point mutations. When point mutations...